D.C. Law 22-18. Medical Marijuana Certified Business Enterprise Preference Temporary Amendment Act of 2017.

AN ACT

To amend, on a temporary basis, the Legalization of Marijuana for Medical Treatment Initiative of 1999 to establish a preference for certified business enterprises that apply for the registration of a dispensary, cultivation center, or testing laboratory.

BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Medical Marijuana Certified Business Enterprise Preference Temporary Amendment Act of 2017".

Sec. 2. Section 7(d) of the Legalization of Marijuana for Medical Treatment Initiative of 1999, effective July 27, 2010 (D.C. Law 18-210; D.C. Official Code § 7-1671.06(d)), is amended by adding a new paragraph (5) to read as follows:

"(5)(A) Any application for registration of a dispensary, cultivation center, or testing laboratory submitted by a certified business enterprise pursuant to this subsection after the effective date of the Medical Marijuana Certified Business Enterprise Preference Emergency Amendment Act of 2017, enacted on June 28, 2017 (D.C. Act 22-83; 64 DCR __), shall be awarded a preference equal to 20 points or 7.5% of the available points, whichever is more.

"(B) For the purposes of this paragraph, the term "certified business enterprise" shall have the same meaning as provided in section 2302(1D) of the Small and Certified Business Enterprise Development and Assistance Act of 2005, effective October 20, 2005 (D.C. Law 16-33; D.C. Official Code § 2-218.02(1D)).".

Sec. 3. Fiscal impact statement.

The Council adopts the fiscal impact statement of the Budget Director as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).

Sec. 4. Effective date.

(a) This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.

(b) This act shall expire after 225 days of its having taken effect.

Law Information

Cites

  • D.C. Law 22-18 (PDF)
  • 64 DCR 6715

Effective

Sept. 6, 2017

Legislative History

Law 22-18, the “Medical Marijuana Certified Business Enterprise Preference Temporary Amendment Act of 2017,” was introduced in the Council and assigned Bill No. 22-305 which was retained by the Council. The bill was adopted on first and second readings on June 6, 2017, and June 27, 2017, respectively. After mayoral review, it was assigned Act No. 22-101 on July 13, 2017, and transmitted to Congress for its review. D.C. Law 22-18 became effective Sept. 6, 2017.